Trial Outcomes & Findings for A Sleep Intervention in Type 1 Diabetes (NCT NCT03617770)

NCT ID: NCT03617770

Last Updated: 2024-03-06

Results Overview

change in minutes of sleep (actigraphy-derived)

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

14 participants

Primary outcome timeframe

Assessing change between two time points:Week 0 to week 8

Results posted on

2024-03-06

Participant Flow

Participant milestones

Participant milestones
Measure
Sleep-Opt-In
Sleep optimization intervention Sleep Opt-In: 8-week intervention that includes a wearable sleep tracker, didactic content, smartphone application and counseling
Healthy Living
Health education Healthy Living: 8-week intervention that includes weekly telephone counseling on healthy living.
Overall Study
STARTED
9
5
Overall Study
COMPLETED
8
5
Overall Study
NOT COMPLETED
1
0

Reasons for withdrawal

Reasons for withdrawal
Measure
Sleep-Opt-In
Sleep optimization intervention Sleep Opt-In: 8-week intervention that includes a wearable sleep tracker, didactic content, smartphone application and counseling
Healthy Living
Health education Healthy Living: 8-week intervention that includes weekly telephone counseling on healthy living.
Overall Study
Lost to Follow-up
1
0

Baseline Characteristics

A Sleep Intervention in Type 1 Diabetes

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Sleep-Opt-In
n=9 Participants
Sleep optimization intervention Sleep Opt-In: 8-week intervention that includes a wearable sleep tracker, didactic content, smartphone application and counseling
Healthy Living
n=5 Participants
Health education Healthy Living: 8-week intervention that includes weekly telephone counseling on healthy living.
Total
n=14 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
9 Participants
n=5 Participants
5 Participants
n=7 Participants
14 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Continuous
30.1 years
STANDARD_DEVIATION 7.1 • n=5 Participants
30.0 years
STANDARD_DEVIATION 7.6 • n=7 Participants
30.1 years
STANDARD_DEVIATION 7.2 • n=5 Participants
Sex: Female, Male
Female
5 Participants
n=5 Participants
4 Participants
n=7 Participants
9 Participants
n=5 Participants
Sex: Female, Male
Male
4 Participants
n=5 Participants
1 Participants
n=7 Participants
5 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
3 Participants
n=5 Participants
0 Participants
n=7 Participants
3 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
6 Participants
n=5 Participants
5 Participants
n=7 Participants
11 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
1 Participants
n=5 Participants
2 Participants
n=7 Participants
3 Participants
n=5 Participants
Race (NIH/OMB)
White
8 Participants
n=5 Participants
3 Participants
n=7 Participants
11 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Region of Enrollment
United States
9 participants
n=5 Participants
5 participants
n=7 Participants
14 participants
n=5 Participants

PRIMARY outcome

Timeframe: Assessing change between two time points:Week 0 to week 8

change in minutes of sleep (actigraphy-derived)

Outcome measures

Outcome measures
Measure
Sleep-Opt-In
n=5 Participants
Sleep optimization intervention Sleep Opt-In: 8-week intervention that includes a wearable sleep tracker, didactic content, smartphone application and counseling
Healthy Living
n=3 Participants
Health education Healthy Living: 8-week intervention that includes weekly telephone counseling on healthy living.
Sleep Duration
385 minutes
Standard Deviation 40
388 minutes
Standard Deviation 39

PRIMARY outcome

Timeframe: Assessing change between two time points: from week 0 to week 8

Change in sleep regularity (variability)

Outcome measures

Outcome measures
Measure
Sleep-Opt-In
n=5 Participants
Sleep optimization intervention Sleep Opt-In: 8-week intervention that includes a wearable sleep tracker, didactic content, smartphone application and counseling
Healthy Living
n=3 Participants
Health education Healthy Living: 8-week intervention that includes weekly telephone counseling on healthy living.
Sleep Regularity
46 minutes
Standard Deviation 20
56 minutes
Standard Deviation 8

SECONDARY outcome

Timeframe: Change between two time points, week 0 to week 8

HbA1c (A1C%)

Outcome measures

Outcome measures
Measure
Sleep-Opt-In
n=5 Participants
Sleep optimization intervention Sleep Opt-In: 8-week intervention that includes a wearable sleep tracker, didactic content, smartphone application and counseling
Healthy Living
n=3 Participants
Health education Healthy Living: 8-week intervention that includes weekly telephone counseling on healthy living.
HbA1c
6.48 % of glucose saturation on hemoglobin
Standard Deviation 0.74
6.7 % of glucose saturation on hemoglobin
Standard Deviation 1.4

SECONDARY outcome

Timeframe: Assessing change between two time points: from week 0 to week 8

Change in glucose variability (CV%) (continuous glucose monitor derived)

Outcome measures

Outcome measures
Measure
Sleep-Opt-In
n=5 Participants
Sleep optimization intervention Sleep Opt-In: 8-week intervention that includes a wearable sleep tracker, didactic content, smartphone application and counseling
Healthy Living
n=3 Participants
Health education Healthy Living: 8-week intervention that includes weekly telephone counseling on healthy living.
Glucose Variability
34.4 percentage of CV
Standard Deviation 4.6
31.6 percentage of CV
Standard Deviation 5.0

SECONDARY outcome

Timeframe: Assessing change between two time points: from week 0 to week 8

Change in Diabetes Distress Scale score, 6-point, 17-item Likert scale. The 17 items are summed. The sum score is divided by 17 to provide a mean item score. Higher scores indicate greater distress. Score interpretation: \< 2.0 = little distress 2.0-2.9 = moderate distress 3.0 or greater = hah distress

Outcome measures

Outcome measures
Measure
Sleep-Opt-In
n=5 Participants
Sleep optimization intervention Sleep Opt-In: 8-week intervention that includes a wearable sleep tracker, didactic content, smartphone application and counseling
Healthy Living
n=3 Participants
Health education Healthy Living: 8-week intervention that includes weekly telephone counseling on healthy living.
Diabetes Distress
1.2 change in score on a scale
Standard Deviation 0.23
3.1 change in score on a scale
Standard Deviation 1.36

Adverse Events

Sleep-Opt-In

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Healthy Living

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Pamela Martyn-Nemeth

University of Illinois at Chicago

Phone: 3129967903

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place